Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Omega to manufacture Covid-19 tests for UK government

Thu, 11th Feb 2021 10:59

(Sharecast News) - Medical diagnostics company Omega Diagnostics has agreed a contract with the Department of Health and Social Care (DHSC), it announced on Thursday, to provide manufacturing capacity for Covid-19 lateral flow antigen tests as part of the UK Government's target of producing two million lateral flow tests per day.
The AIM-traded firm said the intention was that as soon as the DHSC had access to a test that has successfully passed a performance evaluation, the test would be licensed for Omega to manufacture.

As part of the contract, DHSC would loan a number of key pieces of manufacturing equipment.

That, the board said, would facilitate the necessary expansion in production capability in the company's Alva-based facility, to ensure the tests were made available as soon as possible.

The company said it expected that would provide it with the capacity to produce about two million tests per week by the end of April, when combining the government-loaned equipment with its own.

Omega said it expected that capacity to be sufficient to meet the expected demand for lateral flow Covid-19 antigen tests, with enough remaining capacity to be used for 'Visitect' CD4 or Covid-19 antibody tests, according to demand.

"We are delighted to formalise our relationship with the UK Government and to utilise our lateral flow test production capacity to support the Covid-19 mass testing programme being rolled out across this country," said chief executive officer Colin King.

"I appreciate that trading in our core business has been softer than expected for the current financial year, however the on-going opportunity for growth in CD4 testing and food intolerance revenues is unchanged.

"The new financial year will see this growth opportunity realised, and will also see the full impact of Covid-19 antigen testing, and so we are likely to deliver substantial revenue growth compared to this financial year which ends next month."

At 1230 GMT, shares in Omega Diagnostics were up 2.69% at 95.5p.

Related Shares

More News
6 Sep 2023 16:40

TRADING UPDATES: Solid State sees strong orders in security & defence

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

30 Aug 2023 15:44

UK shareholder meetings calendar - next 7 days

22 Aug 2023 10:41

Omega Diagnostics finance director steps down with immediate effect

(Alliance News) - Omega Diagnostics Group PLC on Tuesday said that Group Finance Director Chris Lea has stepped down with immediate effect, as he is b...

3 Aug 2023 14:08

Omega Diagnostics says revenue and loss hurt by operational issues

(Alliance News) - Omega Diagnostics Group PLC on Thursday said its annual loss widened as operational difficulties caused its revenue to plunge.

27 Jul 2023 15:40

UK earnings, trading statements calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.